Conagra Brands: A Deep-Value Investment Analysis

Business understandability score: 4.5/5. Industry attractiveness score: 3/5.

Moat, Management, and Capital Allocation

Start with the moat. Conagra has some moats, but generally not "thick" ones.

Brand advantage: present, but not especially strong. The company does own a set of brands recognized across the U.S., spanning frozen, snack, baking, and shelf-stable occasions; but brand impairments recur, which shows the economic value of these brands cannot always support the original carrying assumptions. In FY2023 the company recognized brand impairments totaling $589.2 million, with Gardein and Birds Eye the two most prominent; FY2024 brought another $526.5 million of goodwill impairment and $430.2 million of other intangible-asset impairment; FY2025 still carried $72.1 million of other intangible-asset impairment. A brand moat that is genuinely "widening" usually does not keep telling you, this frequently, that past assumptions were too optimistic.

Cost and scale advantages: present, but mainly defensive. As of FY2025 the company had 38 U.S. domestic manufacturing facilities, a nationwide manufacturing-and-distribution network spanning multiple categories and temperature zones; it also hedges commodities such as wheat, corn, vegetable oil, pork, dairy, and energy. In other words, it has scale-purchasing and manufacturing-overhead advantages and some supply-chain management capability; but these advantages serve more to dampen volatility than to let it earn returns on capital far above the industry average over the long run.

Channel advantage: present, but carries reflexivity risk. Getting into Walmart, club stores, and the national retail network is itself an advantage, and shelf placement and distribution depth are hard to replicate overnight. But a channel advantage also means dependence on the channel. Conagra's Walmart sales reached 29% of the total in FY2025, which makes its channel capability and its customer-concentration risk almost two sides of the same coin. For a "long-term owner," that concentration means the profit pool is not entirely in the brand owner's hands.

Network effects, switching costs, data advantage, patent/regulatory barriers: essentially weak. Packaged food is not a network-effect industry, consumer switching costs between brands are low, and a data advantage cannot form the closed loop it does for platform companies; recipes, packaging, and trademarks offer some protection, but not a high-barrier patent system. What truly supports the company is brand, shelf access, execution, and scale, not technological exclusivity.

Operating capability: above average. The company is not without achievements in cost management, supply recovery, cash collection, and debt management. FY2025 free cash flow was $1.303 billion, net debt was lower than in FY2024, and by FY2026 Q3 net debt had fallen further to $7.277 billion with net leverage of 3.83x; management also explicitly raised the FY2026 free-cash-flow conversion guidance to roughly 105%. All of this shows the business is not out of control. The issue is that this operating improvement is mainly repair and compression, not proof that the moat is widening.

Capital-allocation ability: more conservative in recent years, but the history is not flawless. Over the past two years Conagra's cash use has looked more like "dividends + debt repayment + small buybacks + small bolt-on M&A." In FY2025 the company paid $669 million in dividends, repurchased just $64 million, spent $230.6 million on M&A, and kept reducing net debt. That allocation is relatively restrained, and I think it is more commendable than "expensive large buybacks." On the other hand, today's $10.50 billion of goodwill plus several consecutive years of impairments show that historical assumptions about M&A and brand value have not consistently been borne out. It is not "reckless," but it is hardly exceptional either.

There is also a new variable on the management front that cannot be ignored: the company's homepage has disclosed that John Brase will become President and CEO on June 1, 2026, with Sean Connolly departing. This means that over the next 12 to 24 months you are not facing "the same management continuing to prove itself," but rather a phase of "the balance sheet left by the old management plus new management beginning to take over execution." For a conservative investor, this lowers the certainty of any current judgment.

On pricing power in an inflationary environment, the company still expects roughly 7% cost inflation in its FY2026 Q3 guidance, including core inflation and the gross impact of tariffs; the company also acknowledges that FY2023 volume was clearly affected by price elasticity, and that FY2025 price/mix was further weighed down by trade investment. So my judgment is: Conagra can raise prices, but not easily; it can stay profitable in a downturn, but not necessarily keep attractive margins; its higher margins in the past were more the combined result of "brand + scale + a cyclical pricing environment" than an absolute structural advantage.

Moat strength score: 2.5/5. Management and capital allocation score: 3/5.

Financial Quality and Owner Earnings

Start with the most important financial picture: over the past five years Conagra's revenue has not truly kept moving up; it has been more of a "flat line plus volatility" shaped by the interplay of inflation, price increases, volume, impairments, and inventory/receivables swings. From FY2021 to FY2025, sales went roughly from $11.2 billion to $11.6 billion, a very limited cumulative increase over four years; adjusted operating margin slipped from 17.5% in FY2021 to 14.1% in FY2025. This shows it is not an organically strong compounder but more a mature enterprise working to defend its profit pool through the food-inflation cycle.

One bright spot in FY2025: despite a less-than-ideal operating environment, the company still delivered $1.303 billion of FY2025 free cash flow, while free cash flow for the first three quarters of FY2026 was $581 million, and management raised full-year free-cash-flow conversion guidance to roughly 105%. But operating cash flow for the first three quarters of FY2026 fell 33.5% year over year, and the company explicitly explained that part of the reason was an early collection of some receivables in the prior-year period, which shows cash-flow quality is broadly acceptable but not entirely free of working-capital noise.

The table below tries to describe financial quality using high-confidence data from the same company's public disclosures over the most recent five years. A few ratios are mechanical calculations I made from those facts, as noted in the table footnotes.

• The FY2024 FCF/net income ratio is heavily distorted, mainly because net income was severely depressed by non-cash impairments, making it unsuitable as a proxy for normalized earnings. The factual data in the table come from the company's FY2021-FY2025 full-year earnings announcements and the FY2025 annual report; several ratios are estimates based on the same-basis financial figures.

On the balance sheet, at the end of FY2025 the company had total liabilities of $12.001 billion and shareholders' equity of $8.933 billion; of which goodwill was $10.502 billion and other intangible assets such as brands/trademarks were $2.421 billion. By FY2026 Q3, cash was $55.1 million, total debt was $7.332 billion, net debt was $7.277 billion, and net leverage was 3.83x, still within investment-grade credit and covenant ranges. On the question of "can it survive," I am not worried about its near-term survival; but on the question of "is this a particularly sturdy balance sheet," the answer is no. It is still a company that relies on operating cash flow for its sense of safety, not one that gives you a margin of safety through net cash and tangible assets.

If you look at it through an ROE/ROIC lens, Conagra's return on capital is at most fair, far from excellent. FY2025 net income was $1.152 billion against year-end shareholders' equity of $8.933 billion, so headline ROE is not low; but that ROE is built on a large base of goodwill and intangibles, and FY2024/FY2025 profits were further distorted by impairments and one-off factors. Using adjusted operating profit, a 23% tax rate, and a simplified "net debt + shareholders' equity" base, I estimate adjusted ROIC for FY2023-FY2025 was roughly in the 7.5% to 8.6% range, more like a "still-makes-money" mature consumer-staples business than a premium enterprise with "consistently superior returns on capital." This level can support a valuation re-rating, but not a high long-term multiple.

On financial integrity, I see no clear evidence of fraud or aggressive accounting. KPMG gave an effective audit conclusion on FY2025 internal controls, and the company disclosed that internal controls are effective. The real issue is not "profit fraud" but past assumptions about brand and goodwill value that leaned optimistic, later corrected by impairments that brought reality back in. For an investor, this is not the same thing as financial fraud, but it is by no means a minor matter, because it keeps eroding your trust in "moat quality."

Owner Earnings Analysis

If I use a Buffett-style "owner earnings" approach, I will deliberately be conservative. Conagra's GAAP net income in FY2025 was $1.1525 billion, with depreciation and amortization of $390.2 million and capex of $389.3 million, almost equal to D&A. Because the company does not explicitly disclose "maintenance capex," and because this is a low-growth, manufacturing-execution-heavy food business, I am reluctant to treat much of the capex as growth spending. The conservative approach is to deduct all capex outright and treat stock-based compensation as a real cost without adding it back. On this basis, the FY2025 owner-earnings floor is actually close to the company's own free cash flow figure of $1.303 billion.

But if I stand here today rather than looking back from FY2025, I would not treat $1.3 billion as a stable midpoint. There are three reasons. First, both operating cash flow and free cash flow for the first three quarters of FY2026 have already declined noticeably. Second, management's FY2026 adjusted-EPS guidance is only $1.70 to $1.85, with free-cash-flow conversion of roughly 105%; on roughly 480 million diluted shares, FY2026 free cash flow works out to roughly $860 million to $930 million. Third, FY2025 operating cash flow contained noise from receivables collection and litigation-related items, which should not be simply treated as permanent profit. Based on these facts, I put the company's more conservative "normalized owner earnings" at $750 million to $850 million, with a neutral estimate of $850 million to $950 million. This is an inference, not a company-disclosed figure.

At the current share price of roughly $13.56 and roughly 478.4 million diluted shares, the company's equity market value is roughly $6.48 billion. On my conservative owner-earnings range of $750 million to $850 million, the current price corresponds to roughly 7.6x to 8.6x owner earnings; on the FY2026 management-guidance-implied free cash flow of $860 million to $930 million, it is around 7x to 7.6x. On a "how cheap" basis this multiple is not expensive, but it equally tells you the market does not believe these cash flows can stay stable over the long run.

Valuation, Margin of Safety, and Relative Comparison

Start with the current market positioning. At the latest price of $13.56, Conagra's equity market value is roughly $6.5 billion; in FY2025 the company paid a quarterly dividend of $0.35, or roughly $1.40 per share annualized, a trailing dividend yield above 10%; in FY2026 Q3 net debt was $7.277 billion and TTM adjusted EBITDA was $1.900 billion, implying an enterprise value of roughly $13.8 billion and EV/TTM adjusted EBITDA of roughly 7.2x. Looking only at FY2025, P/B is roughly 0.7x and P/FCF is roughly 5.0x; on FY2026 guidance, the market is paying something more like about 8x forward adjusted EPS. On "the multiple alone," it is clearly cheap.

Owner-Earnings Discount Method

I build the valuation on the conservative owner-earnings basis above rather than on FY2025's peak free cash flow. To avoid making it "too easily cheap," I use stricter assumptions:

Among these figures, the parts that are assumptions rather than facts are the owner-earnings midpoint, the growth rate, the discount rate, and the terminal growth rate; but they are all set around FY2025 free cash flow, FY2026 guidance free cash flow, and the current leverage level. My conservative intrinsic-value range is $12 to $16, my fair intrinsic-value range is $18 to $20, and my optimistic intrinsic-value range is $23 to $25. At the current $13.56, the market price sits roughly between "near the low end of the conservative value" and "a clear discount to fair value." That is also why I am unwilling to call it a straight "Buy": the cheapness is real, but the margin of safety is not so large that it can ignore operating quality.

Relative Valuation Method

On relative valuation, CAG is indeed cheap. At the current price, CAG's trailing multiple on FY2025 adjusted EPS is roughly 5.9x, its forward multiple on FY2026 adjusted-EPS guidance is roughly 8.0x, and its multiple on FY2025 free cash flow is roughly 5.0x. By comparison, Campbell's official investor page shows FY2025 sales of roughly $10.3 billion, adjusted EPS of $2.97, and operating cash flow of $1.1 billion; at Campbell's current price of roughly $28.17, its multiple on FY2025 adjusted EPS is roughly 9.5x. This shows the market's discount on Conagra is not simply "all food stocks are cheap," but that Conagra is cheaper than another also-not-high-growth branded-food peer. I think much of this discount is broadly reasonable, but it already prices in a fair amount of negative expectations.

General Mills, as a larger, more diversified peer generally viewed by the market as higher quality, should command a valuation premium. Officially disclosed General Mills operating cash flow for the first nine months of FY2026 was $1.614 billion, but it too recently faces pressure from volume, input costs, and organizational restructuring. Because I did not obtain its complete, same-basis, latest annualized EV/EBITDA and P/FCF data this time, I will not force a precise table and will give only a qualitative conclusion: Conagra's low valuation does not mean it is better than General Mills; it only means the market thinks it is worse, and the discount it now offers is already deep.

Asset-Value or Liquidation-Value Method

On an asset basis, Conagra does not look good. FY2025 shareholders' equity was roughly $8.933 billion, but goodwill was $10.502 billion and brands and other intangibles were $2.421 billion, the two together clearly exceeding the equity book value. This means the company's tangible net worth is negative, and liquidation value cannot provide a margin of safety. Put another way, buying CAG essentially requires betting on its going-concern value and real cash flow, not on book assets. For a balanced, conservatively inclined investor, this is a very important "reason not to buy."

Margin-of-Safety Assessment

If you view Conagra as an ordinary mature food company and believe its normalized owner earnings are at least around $800 million, then the current price has some appeal; but if you view it as a company with a continuously narrowing moat, unsteady volumes, and future free cash flow that could drop to $700 million or even lower, then the current price does not carry a particularly thick margin of safety. Put another way, the most fragile valuation assumption is not the growth rate but exactly where the "cash-flow bottom" lies. Once the owner-earnings midpoint falls from $850 million to $700 million, the current price quickly shifts from "somewhat cheap" to "only looks cheap."

Based on this logic, I offer the following operating ranges: Ideal buy-price range: $11 to $13. Acceptable holding-price range: $13 to $18. Clearly overvalued range: above $22.

This is not a conclusion accurate to the cent, but a conservative range derived from the combination of three factors: "cash-flow bottom + leverage + moat width." The current $13.56 is a bit above my ideal buy range, so the conclusion is Watch, not buy now.

Risks, the Bear Case, and the Investment Checklist

The most important risk is not short-term price volatility but permanent loss of capital. For Conagra, the most realistic risks fall into several categories: First, competition and private-label risk. The industry is fiercely competitive, private labels keep growing, and price-sensitive consumers are more likely to switch to cheaper substitutes. Second, customer-concentration risk. Walmart accounts for roughly 29% of sales, which amplifies bargaining and shelf-space risk. Third, cost and tariff risk. Conagra's own guidance is for roughly 7% cost inflation in FY2026, and official industry bodies also note that certain tariffs push up CPG manufacturing-chain costs. Fourth, goodwill/brand impairment risk. Recurring impairments show brand value is not solid, and if volume and margins are revised down again in the future, equity and market confidence could keep being eroded. Fifth, leverage risk. Although near-term liquidity is not in question and the credit rating remains investment-grade, net leverage is still around 3.8x, above my comfort line for a "very sturdy consumer stock." Sixth, management-transition risk. John Brase is about to take over as CEO, and the future strategic cadence and capital-allocation tilt remain to be verified.

The strongest bear case is actually quite powerful: this may be a value trap that "looks very cheap." The bears would say that although Conagra's business is stable, it lacks strong enough brand barriers to fend off the channel and private labels; every price increase hurts volume, and recurring impairments show that the past brand-and-M&A logic did not truly build long-term excess returns; net debt also leaves the company little room to make big mistakes at the wrong time. As long as volume keeps drifting down slightly and the margin slides from the 14% adjusted-basis level further toward 12% or lower, the free-cash-flow midpoint may no longer be $800 million to $900 million but only $600 million to $700 million; in that scenario, today's low valuation is not necessarily cheap. This bear case, in my view, cannot be taken lightly.

What facts would overturn the bull case? I think there are at least four. First, over the next four to six quarters, organic volume keeps deteriorating rather than stabilizing. Second, adjusted operating margin cannot return to the low-to-mid teens and instead stays stuck around 10% to 11% over the long run. Third, net leverage rises again above 4x, or investment-grade credit margins clearly deteriorate. Fourth, the company sacrifices the balance sheet to defend the dividend, or large impairments recur, especially with core frozen and snack brands continuing to be written down. As soon as these facts appear, I would lean toward admitting that "cheap does not mean worth owning."

Compared with other opportunities, my conclusion is on the restrained side. Relative to the S&P 500, Conagra's own 5-year and 10-year total-shareholder-return charts in the 10-K both clearly lag: as of FY2025, Conagra's 10-year cumulative return came back to roughly 102, while the S&P 500 was around 327 and the S&P 500 Packaged Foods Index was around 140. This shows that over the past decade you did not earn an "enterprise-quality dividend" from holding Conagra. So you buy it not because it beat the index in the past, but only because you believe from this price onward, the future return/risk ratio is better than the index. For a broad-index investor, there is no clear evidence that CAG is "meaningfully better than buying the index"; for a deep-value investor, it can be a candidate, but not necessarily a top-five name in the portfolio.

The U.S. Treasury continually publishes risk-free rate-curve data such as the 10-year note; compared with such Treasuries, Conagra's current dividend yield is meaningfully higher, but that absolutely does not make it a "better bond substitute." The coupon certainty of Treasuries is far higher than Conagra's, and Conagra's high yield precisely reflects market concern about its operations and leverage. In my view, CAG's expected return is sufficient to compensate for this extra risk only when the price is low enough and the cash-flow bottom is relatively stable.

Investment Checklist

Open Questions and Limitations

This report has three main limitations: First, maintenance capex is not disclosed separately by the company, so owner earnings use a conservative-range method rather than a precise value. Second, in the peer comparison, I did not pull complete, same-time-point, same-basis EV/EBITDA and P/FCF for General Mills and Kraft Heinz, so the relative-valuation conclusion is directionally valid but limited in precision. Third, on the risk-free yield, this report only confirmed that the U.S. Treasury provides official daily curve data and did not incorporate a precise 10-year value from any single day into the valuation model; my discount rate therefore leans more on "enterprise risk compensation" than on mechanically applying the day's Treasury yield.

Final Investment Conclusion

【Final Rating】 Watch.

【One-Sentence Investment Thesis】 Conagra is not a "high-quality long-term compounder" but a branded-food company whose cash flow still has resilience and whose valuation is already very low, but whose moat is thinning and whose leverage is not light; it now looks more like a low-valuation name worth tracking than a high-certainty opportunity worth buying heavily right away.

【Core Bull Case】 The company sells high-repeat-consumption packaged food; demand will not disappear, the business model is simple, and the cash flow is understandable. The current valuation is very low; on FY2025/FY2026 bases, P/FCF, forward P/E, and EV/EBITDA are all at relatively low levels. The company is still deleveraging, with FY2026 Q3 net debt and leverage clearly lower than the prior-year period. Capital allocation has become restrained over the past two years, with no aggressive buybacks; cash mainly goes to dividends, debt repayment, and small bolt-on M&A. Even with margins under pressure, the company keeps investment-grade credit and positive free cash flow, which gives the business some resilience.

【Core Bear Case】 The moat is not deep, and successive large goodwill and brand impairments are already a strong alarm. Retail customers are overly concentrated, with Walmart at roughly 29% of revenue, giving the channel leverage over the brand owner. Pricing power is limited; when price drove sales over the past two years, volume and consumption trends came under clear pressure. Net leverage is still on the high side, meaning the "cheapness" already embeds real financial risk. A CEO transition is imminent, and future execution and capital allocation still need to be re-observed.

【Key Assumptions】 The company's normalized owner earnings over the next two to three years are no less than $750 million to $850 million. Net leverage can gradually move toward around 3.5x rather than rising again. Volumes for core brands such as frozen and snacks can at least stabilize and stop deteriorating. No new round of large core-brand impairment occurs in the future.

【Fair Buy Price】 $11 to $13. The basis: on a conservative owner-earnings discount method, conservative intrinsic value is broadly $12 to $16; to leave an extra 20% to 25% buffer for "a weaker moat + non-light leverage + a CEO transition," the buy point should sit closer to the low end of the conservative range. The current $13.56 is not absurd, but it is not yet cheap enough to make me ignore these risks.

【Target Holding Period】 At least 5 to 10 years, but not the "buy and forget" type; rather a long-term investment that requires quarterly tracking of operating and debt trajectories.

【Expected Annualized Return】 Conservative scenario: 4% to 6%. This assumes a low cash-flow midpoint, no multiple expansion, and a dividend that is covered but grows little. Neutral scenario: 8% to 10%. This assumes owner earnings return to the $850 million to $900 million range, leverage keeps falling, and the multiple re-rates modestly. Optimistic scenario: 11% to 13%. This assumes volumes stabilize, margins improve, and the market acknowledges its cash-flow resilience and grants a consumer-stock valuation closer to the median.

【Maximum Loss Risk】 I think the worst case could see a 40% to 60% permanent loss of capital. The trigger mechanism is usually: intensifying competition causing volume and margins to fall together, the dividend being forced down, further impairments harming credit and market confidence, and debt amplifying equity volatility. At that point the stock could slide from "low valuation" into a "low-quality, low-valuation" trap.

【Tracking Metrics】 For the most critical metrics to track going forward, I suggest watching only the following: The split between organic volume and price/mix. Adjusted operating margin. Free cash flow and free-cash-flow conversion. Net debt / EBITDA. Walmart sales share and accounts-receivable share. Core-brand market share and signs of impairment. Cost inflation and tariff impact. Dividend coverage ratio. Working capital, especially changes in receivables and inventory. The sequence of dividends, debt repayment, M&A, and buybacks after the new CEO takes office.

【Signals That Trigger a Re-evaluation】 Several consecutive quarters of negative organic volume with no improvement. Adjusted operating margin falling below roughly 11% over the long run. Net leverage rising again above 4x. Large brand or goodwill impairment recurring. Sacrificing deleveraging to maintain the dividend. Customer concentration continuing to rise, or major-customer terms clearly deteriorating. New management launching a high-premium large acquisition.

【Final Recommendation】 Viewed coolly, this is not a "I have finally found a great company" opportunity; it looks more like a "the market has written all the problems into the price, but the problems are not yet fully resolved" opportunity. For long-term investors who want quality and want to sleep soundly, I would put it on the watch list rather than buy it directly; for value investors who accept low growth and prize cash-flow yield, you can seriously study it and build a position gradually in the $11 to $13 range, but the position must have discipline, and you must write down in advance "under what conditions I admit I am wrong and exit." The real key is not whether it is cheap, but whether you can honestly admit: this is a cheap ordinary company, not a cheap exceptional one.

This report is based on public information and does not constitute investment advice. Markets carry risk; invest with caution.